\
&
Contact us
\
&
Contact us
NCP Flanders is conducting a short satisfaction survey to gather valuable feedback and suggestions on the NCP services. The survey is organised into three sections: NCP Flanders assistance, info sessions, and NCP Flanders website & LinkedIn. If you are not familiar with one of these sections, the survey will automatically guide you to the next section. The survey is fully anonymous and will remain open until 24 July 2026. The NCP Flanders team would greatly appreciate it if you could take a few minutes to fill in the survey and provide your opinion via this link. If you would like to get in touch NCP Flanders, please mail to info@ncpflanders.be
The results of the 2026 European Research Council (ERC) Proof of Concept (PoC) Grant call (first deadline date 17 March 2026) were published. Principal Investigators (PIs) with a main ERC Grant that is ongoing or ended after 1 January 2025 are eligible to participate in an ERC 2026 PoC Grant. The ERC PoC Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to PIs whose proposals draw substantially on their ERC funded research. For this first call in total 182 ERC PoC Grants were awarded to PIs working in 21 different countries across Europe, EU member states and associated countries. In the ERCEA news article more background on the evaluation results and the full list of winning projects (deadline 1) are highlighted. Among the 182 selected researchers are nine based at Flemish host institutions. The projects of several PIs are presented in the news articles of the Vlaams Instituut voor Biotechnologie (web article) and Universiteit Antwerpen (web article). The second and last deadline date of the 2026 call is 17 September 2026. Stein AERTS, Vlaams Instituut voor Biotechnologie, CellTuned: AI-driven regulatory genomics for precision therapy, which builds on research funded by the 2021 Advanced Grant Genome2Cells - Decoding animal genomes into cell types and is the fourth ERC Grant awarded to him (1 Consolidator, 1 Advanced and 2 Proof of Concept Grants). Rob AMELOOT, KU Leuven, FLASH-IT - Flash Sorption Analysis for Ultra-Fast Adsorbent Evaluation, which builds on research funded by the 2021 Consolidator Grant KISSIES - Kinetic selectivity in molecular sieve sensors and is the sixth ERC Grant awarded to him (1 Starting, 1 Consolidator and 4 Proof of Concept Grants). Bart DE STROOPER, Vlaams Instituut voor Biotechnologie, AD-LINK: Reversing Early Aβ-Driven Network Hyperexcitability, which builds on research funded by the 2024 Advanced Grant XenoAD - Modelling the impact of aging in sporadic Alzheimer’s disease and is the fifth ERC Grant awarded to him (3 Advanced and 2 Proof of Concept Grants). Dominique DEVRIESE, KU Leuven, MicroVerif - Rigorous Micro-Verification of Legacy Embedded Software Systems, which builds on research funded by the 2021 Starting Grant UniversalContracts - Formalizing, Verifying and Applying ISA Security Guarantees as Universal Contracts. Diether LAMBRECHTS, Vlaams Instituut voor Biotechnologie, TWISTAR - AN OFF-THE-SHELF VACCINE FOR TRIPLE-NEGATIVE BREAST CANCER, which builds on research funded by the 2021 Advanced Grant EXPAND IT - EXPANDing Immune Cells and their Tumor Antigens during checkpoint immunotherapy and is the fourth ERC Grant awarded to him (1 Consolidator, 1 Advanced and 2 Proof of Concept Grants). Sarah LEBEER, Universiteit Antwerpen, Lab-Protect: Translating phyllosphere-adapted microbial insights into a new class of lactobacilli-based biocontrol solutions, which builds on research funded by the 2019 Starting Grant Lacto-BE - Advancing Lactobacillus’ beneficial potential and is the third ERC Grant awarded to her (1 Starting and 2 Proof of Concept Grants). Renzo MANCUSO, Vlaams Instituut voor Biotechnologie, MicroTreatAD - Engineering microglia to treat Alzheimer’s disease, which builds on research funded by the 2021 Starting Grant XenoMicrogliaAD - Deciphering the microglia-neuron interactions in human Alzheimer's disease. Jan STEYAERT, Vlaams Instituut voor Biotechnologie, DUAL-PAM - In vivo validation of a novel, high precision Positive Allosteric Modulation-based therapy for immune inflammatory diseases, which builds on research funded by the 2023 Advanced Grant Allosteris - Allosteric modulation of immune checkpoint complexes as a new mode of therapeutic intervention in immunotherapy and is the third ERC Grant awarded to him (1 Advanced and 2 Proof of Concept Grants). Xing YANG, KU Leuven, PRISM-ION - From Discovery to Scale – Precision Membranes for Critical Ion Recover, which builds on research funded by the 2022 Starting Grant IonFracMem - Enabling Targeted Fractionation of Ions via Facilitated Transport Membranes.
EIT Health’s Innovation Uptake Call focuses on mature digital, data-driven and AI-powered solutions and seeks to support the last steps towards commercialisation. Applicants must apply as a consortium of at least two independent legal entities from different countries. The consortium must include partners from at least two sides of the Knowledge Triangle: industry, research and education. Projects must be led by a commercialising entity, either an SME or another industry player, responsible for bringing the solution to market. The maximum funding per project is €650,000 (total budget €5,2 million) and the grant may cover up to 50% of total project costs, so co-funding is required. Funded activities may include commercialisation pilots in real-world healthcare settings, usability testing and market adaptation, go-to-market strategy, business model validation and health economics analysis. The call was opened on 24 June 2026 and will close on 16 September 2026. An information session is scheduled for 15 July 2026 from 12:30 to 13:30 CET, and an open Q&A session for 1 September 2026 at 11:00 CET. More information is available on the website of the call. Background: The European institute of Innovation and Technology (EIT) stands at the crossroad of business creation, innovation and education. It consists of ten knowledge and innovation communities. The overall objective is to transform promising innovations into succesful companies.
The Commission has asked Health NCPs to communicate the information below to the Cluster Health applicant community:The Commission has moved forward the deadlines for two upcoming Cluster health calls to February 2027. This means many health call topics will have a deadline on 17th February 2027 (instead of April 2027). Herewith an overview of the new opening & closing dates:📍 HORIZON-HLTH-2027-01Opening: 29 Oct 2026Deadline(s): 17 Feb 2027 📍 HORIZON-HLTH-2027-02Opening: 29 Oct 2026Deadline(s): 17 Feb 2027 (First Stage), 16 Sep 2027 (Second Stage)📍 HORIZON-HLTH-2027-03Opening: 03 Jun 2027Deadline(s): 16 Sep 2027! Note that the current version of the amended draft health work programme that is publicly available on the Comitology register does not yet include all new deadlines.
Flemish companies active in biotechnology can apply to the Eureka Biotech Call for Innovation Projects, an international funding opportunity supporting collaborative research and innovation projects with partners from participating countries. Each country or region assesses and funds its own project partners. For Flanders, VLAIO participates through its regular support for research and development projects, in accordance with the applicable criteria.Through this Eureka call, Flanders aims to encourage companies to set up research and development projects in biotechnology fields such as medicine, bioinformatics, pharmaceutical products and services, life sciences, digitalisation and (bio)process technology (non-exhaustive list) – in collaboration with partners. Besides the joint Eureka application, Flemish participants must also submit a project proposal to VLAIO and are encouraged to contact VLAIO early for an eligibility check and proposal guidance. The Eureka submission deadline is 25 September 2026. The VLAIO proposal deadline is 9 October 2026 12:00 CEST. More information and details on the dedicated VLAIO webpage.
Sign up for personalised information!
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you. By signing up, you can opt in for email notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The EITHOS project, funded under Horizon Europe Cluster 3 call “Online identity theft is countered”, aims to develop a “European Identity Theft Observatory System” (EITHOS). The system will provide easy access to information and intelligence about previous and current identity theft related trends to empower EU citizens, Law Enforcements Agencies (LEAs), and policy makers to further contribute to the prevention, detection, and investigation of crimes related to online identity theft. The Cyber and Data Security Lab (CDSL), part of the Law, Science, Technology and Society (LSTS) Research Group at Vrije Universiteit Brussel (VUB), is one of the 12 partners in the EITHOS consortium, contributing its vast expertise on legal aspects of data protection, cybersecurity and information security law and policy.
